ArticleStatistics in biosciences2024
Set-Based Tests for Genetic Association Studies with Interval-Censored Competing Risks Outcomes.
Article in Statistics in biosciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Over the past decade, massive genetic compendiums such as the UK Biobank have gathered extensive genetic and phenotypic data that hold the potential to provide unparalleled insight into the genetic etiologies of various complex diseases. However, much of the disease information is collected as time-to-event outcomes in interval-censored form, and conventional tools for genetic association analysis are often not available for this type of data. For example, set-based inference for common and rare variants analysis is a fundamental investigation in germline genetics studies, but there is a lack of approaches that can perform set-based testing when the interval-censored outcome of interest is subject to the competing risk of another event. To address the need, this work proposes two set-based inference procedures for interval-censored data with competing risks, applicable to rare variants and general genotype sets as well. The interval-censored competing risks sequence kernel association test (crSKAT) is a variance components approach that is powerful when genetic variants in a set demonstrate heterogeneous signals. The interval-censored competing risks Burden (crBurden) test is more powerful when variant signals are homogeneous. Simulation studies show the superiority of the newly developed methods in comparison to ad-hoc alternatives, as evidenced by their ability to control the type I error rate and to improve power. The proposed tests are applied to the UK Biobank to search for genes associated with fracture risk while accounting for death as a competing outcome.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.